Keila DePape

1 week ago | phys.org | Keila DePape

McGill University researchers have developed an AI-powered method to verify the origin of honey, ensuring that what's on the label matches what's in the jar. The breakthrough, published in Analytical Chemistry, offers a potential solution to a long-standing problem. "Honey is one of the most fraud-prone commodities in global trade.

2 weeks ago | medicalxpress.com | Keila DePape

A McGill University-led study has found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with psychosis. The findings are published in the journal JAMA Psychiatry. "This could help explain why cannabis use increases the risk of hallucinations and delusions, key symptoms of schizophrenia and other psychotic disorders," said first author Jessica Ahrens, a Ph.D. student in McGill's Integrated Program in Neuroscience.

3 weeks ago | medicalxpress.com | Keila DePape

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The researchers looked at how often people with immune-mediated inflammatory diseases (IMIDs) got COVID-19 despite having received at least three doses of an mRNA COVID-19 vaccine.

1 month ago | medicalxpress.com | Keila DePape

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder (iRBD) causes people to physically act out their dreams while sleeping. The disorder is also associated with a very high risk of Parkinson's disease and a related condition called Dementia with Lewy Bodies.

2 months ago | medicalxpress.com | Keila DePape

A component found in all fungi may provide a shield against flu-related lung damage, according to a new study. A team of scientists led by Maziar Divangahi, a Professor in McGill's Faculty of Medicine and Health Sciences and Senior Scientist at the Research Institute of the McGill University Health Center, demonstrated that beta-glucan, administered to mice before their exposure to influenza, can reduce lung damage, improve lung function and lower the risk of illness and death.